The leaves of Mangifera indica were assessed for antidiabetic properties using normoglycaemic, glucose-induced hyperglycaemia and streptozotocin (STZ) induced diabetic mice. The aqueous extract produced a reduction of blood glucose level in normoglycaemic and glucose-induced hyperglycaemia, but did not have any effect on streptozotocin-induced diabetic mice. The hypoglycaemic effect of the aqueous extract was compared with that of an oral dose of chlorpropamide under the same conditions. The results of this study indicate that the aqueous extract of the leaves of Mangifera indica possess hypoglycaemic activity.

No abstract

The leaves of Mangifera indica are used as an antidiabetic agent in Nigerian folk medicine. To determine whether or not there is a scientific basis for this use, the effect of the aqueous extract of the leaves on blood glucose level was assessed in normoglycaemic, glucose - induced hyperglycaemic and streptozotocin (STZ)-induced diabetic rats. The aqueous extract given orally (1 g/kg) did not alter the blood glucose levels in either normoglycaemic or STZ-induced diabetic rats. In glucose - induced hyperglycaemia, however, antidiabetic activity was seen when the extract and glucose were administered simultaneously and also when the extract was given to the rats 60 min before the glucose. The hypoglycaemic effect of the aqueous extract was compared with that of an oral dose of chlorpropamide (200 mg/kg) under the same conditions. The results of this study indicate that the aqueous extract of the leaves of Mangifera indica possess hypoglycaemic activity. This action may be due to an intestinal reduction of the absorption of glucose. However, other different mechanisms of action cannot be excluded.

Although the occurrence of the taurine conjugation mechanism for various xenobiotic acids is well established, nothing is known of the source of the taurine used for this conjugation. [14C]Taurine was administered alone and in combination with 2-naphthylacetic acid or clofibric acid (both of which are known to form taurine conjugates) to to ferrets, and the 0--24 h urine collected. Of the dose of [14C]taurine, 26% was recovered in the urine in 24 h and the only 14C-containing material present was unchanged taurine. When either 2-naphthylacetic acid or clofibric acid was co-administered with [14C]taurine, 21 and 17%, respectively, of the 14C dose was recovered in the 0--24 h urine. In both cases, two 14C compounds were present--unchanged taurine (minor) and the taurine conjugate of the acid in question (major). Comparison of these results with those previously obtained with 14C-labelled 2-naphthylacetic and clofibric acids, shows that the taurine used for their conjugation is derived from a pool freely accessible to exogenous taurine. The results are discussed in terms of the availability for metabolic utilization of taurine in the animal body, and of the use of co-administration of [14C]taurine with a xenobiotic acid for the identification of taurine conjugates.